| Date Filed | Type | Description |
| 10/04/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 388 shares
@ $22.85, valued at
$8.9k
|
|
| 08/09/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 391 shares
@ $30.48, valued at
$11.9k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2023 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Walsh Kathleen E (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Fishman Mark (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Ho Carole (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/05/2023 |
4
| Evans John M. (CEO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 5,161 shares
@ $30.31, valued at
$156.4k
Sold 6,493 shares
@ $29.0935, valued at
$188.9k
|
|
| 04/05/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 1,918 shares
@ $30.31, valued at
$58.1k
Sold 1,754 shares
@ $29.0929, valued at
$51k
|
|
| 04/05/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 931 shares
@ $30.31, valued at
$28.2k
Sold 1,161 shares
@ $29.0931, valued at
$33.8k
|
|
| 04/05/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 4,445 shares
@ $30.31, valued at
$134.7k
Sold 10,493 shares
@ $29.7664, valued at
$312.3k
Sold 1,161 shares
@ $29.0926, valued at
$33.8k
|
|
| 04/05/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 2,454 shares
@ $30.31, valued at
$74.4k
Sold 2,186 shares
@ $29.0931, valued at
$63.6k
|
|
| 03/31/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 17,500 shares
@ $0
Exercised 6,272 options to buy
@ $7.22, valued at
$45.3k
Exercised 2,669 options to buy
@ $7.22, valued at
$19.3k
|
|
| 03/31/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $43.45, valued at
$1.7M
|
|
| 03/31/2023 |
4
| Evans John M. (CEO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Small acquisition of 225 shares
@ $0
Granted 56,250 shares
@ $0
Granted 112,500 options to buy
@ $43.45, valued at
$4.9M
Exercised 13,850 options to buy
@ $7.22, valued at
$100k
|
|
| 03/31/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 03/31/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 20,000 options to buy
@ $43.45, valued at
$869k
|
|
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/30/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 1,102 shares
@ $45.1572, valued at
$49.8k
Sold 36,152 shares
@ $45.0804, valued at
$1.6M
Exercised 1,102 options to buy
@ $13.68, valued at
$15.1k
Exercised 36,152 options to buy
@ $13.68, valued at
$494.6k
|
|
| 01/25/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 5,426 shares
@ $45.0221, valued at
$244.3k
Sold 14,810 shares
@ $45.014, valued at
$666.7k
Exercised 5,426 options to buy
@ $13.68, valued at
$74.2k
Exercised 14,810 options to buy
@ $13.68, valued at
$202.6k
|
|
| 01/20/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 47,195 shares
@ $45.14, valued at
$2.1M
Exercised 39,886 options to buy
@ $13.68, valued at
$545.6k
|
|
| 01/05/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 37,525 shares
@ $37.14, valued at
$1.4M
Sold 13,704 shares
@ $37.99, valued at
$520.6k
Sold 1,900 shares
@ $39.07, valued at
$74.2k
Sold 600 shares
@ $39.94, valued at
$24k
Exercised 9,106 options to buy
@ $0.67, valued at
$6.1k
Exercised 4,326 options to buy
@ $4.22, valued at
$18.3k
Exercised 40,297 options to buy
@ $0.67, valued at
$27k
|
|
| 01/03/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Exercised 4,500 options to buy
@ $0.67, valued at
$3k
|
|
| 12/20/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/08/2022 |
4
| FMR LLC (10% Owner) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Disposed of 25,620 shares
@ $0
Acquired 551 shares
@ $0
Sold 551 shares
@ $54.25, valued at
$29.9k
|
|
| 09/02/2022 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
| 09/02/2022 |
4
| Ho Carole (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
| 09/02/2022 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
|